IO Biotech (IOBT) Short Interest Ratio & Short Volume → Warning: this could blow your mind (From DTI) (Ad) Free IOBT Stock Alerts $1.73 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media IO Biotech Short Interest DataCurrent Short Volume81,600 sharesPrevious Short Volume54,300 sharesChange Vs. Previous Month+50.28%Dollar Volume Sold Short$134,640.00Short Interest Ratio / Days to Cover0.6Last Record DateMarch 15, 2024Outstanding Shares65,880,000 sharesFloat Size41,350,000 sharesShort Percent of Float0.20%Today's Trading Volume53,556 sharesAverage Trading Volume141,980 sharesToday's Volume Vs. Average38% Short Selling IO Biotech ? Sign up to receive the latest short interest report for IO Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIOBT Short Interest Over TimeIOBT Days to Cover Over TimeIOBT Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here IO Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202481,600 shares $134,640.00 +50.3%0.2%0.6 $1.65 2/29/202454,300 shares $86,880.00 +10.4%0.1%0.4 $1.60 2/15/202449,200 shares $74,784.00 +2.5%0.1%0.3 $1.52 1/31/202448,000 shares $83,520.00 -30.9%0.1%0.5 $1.74 1/15/202469,500 shares $131,355.00 -14.1%0.2%0.7 $1.89 12/31/202380,900 shares $152,092.00 -56.4%0.2%0.6 $1.88 Get the Latest News and Ratings for IOBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter. 12/15/2023185,500 shares $262,482.50 -7.7%0.5%1.5 $1.42 11/30/2023200,900 shares $235,053.00 +17.0%0.6%1.3 $1.17 11/15/2023171,700 shares $168,266.00 +3.5%0.5%1.2 $0.98 10/31/2023165,900 shares $142,159.71 +26.9%0.9%1 $0.86 10/15/2023130,700 shares $150,305.00 +12.4%0.7%0.8 $1.15 9/30/2023116,300 shares $163,983.00 -57.2%0.7%0.9 $1.41 9/15/2023271,800 shares $385,956.00 -57.0%1.5%2.1 $1.42 8/31/2023631,700 shares $1.16 million +15.5%3.6%3 $1.84 8/15/2023546,900 shares $1.09 million +29.9%3.1%2.7 $2.00 7/31/2023421,000 shares $774,640.00 -5.9%2.1%2.4 $1.84 7/15/2023447,500 shares $796,550.00 +5.7%2.3%2.8 $1.78 6/30/2023423,200 shares $829,472.00 -11.2%2.2%2.7 $1.96 6/15/2023476,300 shares $976,415.00 +11.9%2.4%3.2 $2.05 5/31/2023425,700 shares $885,456.00 +36.3%2.2%13.2 $2.08 5/15/2023312,400 shares $624,800.00 No Change1.7%11.2 $2.00 10/31/20229,400 shares $23,218.00 +59.3%0.1%0.2 $2.47 10/15/20225,900 shares $14,042.00 -14.5%0.0%0.1 $2.38 9/30/20226,900 shares $18,699.00 -25.0%0.0%0.2 $2.71 9/15/20229,200 shares $26,680.00 +13.6%0.1%0.2 $2.90 8/31/20228,100 shares $26,892.00 +1,250.0%0.0%0.2 $3.32 8/15/2022600 shares $2,406.00 -50.0%N/A0 $4.01 7/31/20221,200 shares $4,644.00 -62.5%0.0%0 $3.87 7/15/20223,200 shares $13,440.00 -74.2%0.0%0.1 $4.20 6/30/202212,400 shares $57,908.00 +106.7%0.1%0.2 $4.67 6/15/20226,000 shares $23,640.00 +106.9%0.0%0.1 $3.94 5/31/20222,900 shares $14,007.00 -44.2%0.0%0.1 $4.83 5/15/20225,200 shares $39,156.00 -50.0%0.0%0.1 $7.53 4/30/202210,400 shares $75,400.00 -24.6%0.1%0.3 $7.25 4/15/202213,800 shares $99,222.00 +68.3%0.1%0.5 $7.19 3/31/20228,200 shares $43,460.00 -78.3%N/A0 $5.30 3/15/202237,700 shares $143,260.00 +19.7%0.3%1.4 $3.80 2/28/202231,500 shares $226,170.00 -20.1%0.2%0.8 $7.18 2/15/202239,400 shares $335,688.00 -14.5%0.3%0.4 $8.52 1/31/202246,100 shares $394,155.00 -28.5%0.3%0.4 $8.55Urgent: Protect Your Investments from a Chinese Invasion (Ad)An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> IOBT Short Interest - Frequently Asked Questions What is IO Biotech's current short interest? Short interest is the volume of IO Biotech shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 81,600 shares of IOBT short. 0.20% of IO Biotech's shares are currently sold short. Learn More on IO Biotech's current short interest. What is a good short interest ratio for IO Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IOBT shares currently have a short interest ratio of 1.0. Learn More on IO Biotech's short interest ratio. What is a good short interest percentage for IO Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.20% of IO Biotech's floating shares are currently sold short. Is IO Biotech's short interest increasing or decreasing? IO Biotech saw a increase in short interest in March. As of March 15th, there was short interest totaling 81,600 shares, an increase of 50.3% from the previous total of 54,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IO Biotech's float size? IO Biotech currently has issued a total of 65,880,000 shares. Some of IO Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IO Biotech currently has a public float of 41,350,000 shares. How does IO Biotech's short interest compare to its competitors? 0.20% of IO Biotech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to IO Biotech: Adagene Inc. (0.06%), Sagimet Biosciences Inc. (14.76%), Oramed Pharmaceuticals Inc. (1.19%), Vincerx Pharma, Inc. (6.42%), Allakos Inc. (6.37%), ProPhase Labs, Inc. (1.76%), Seres Therapeutics, Inc. (12.18%), Societal CDMO, Inc. (0.34%), Lantern Pharma Inc. (1.83%), Reviva Pharmaceuticals Holdings, Inc. (2.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short IO Biotech stock? Short selling IOBT is an investing strategy that aims to generate trading profit from IO Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IO Biotech? A short squeeze for IO Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IOBT, which in turn drives the price of the stock up even further. How often is IO Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IOBT, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ADAG Short Interest SGMT Short Interest ORMP Short Interest VINC Short Interest ALLK Short Interest PRPH Short Interest MCRB Short Interest SCTL Short Interest LTRN Short Interest RVPH Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IOBT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory